Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Judith Bovée Karoly Szuhai Stefan Sleijfer Hans J. Gelderblom David G P van IJzendoorn Geert J.L.H. van Leenders |
| Publication date | March 6, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |